Orangewood Labs
-69%
est. 2Y upside i
Orangewood Labs makes worlds most affordable and easiest AI robot arms
Rank
#1476
Sector
Robotics, AI, Industrial Automation
Est. Liquidity
~4Y
Data Quality
Data: MediumOrangewood Labs presents a moderate upside opportunity for a job seeker, driven by its innovative AI-powered robotic arms and a strong focus on the underserved SMB market.
Last updated: March 10, 2026
Orangewood Labs' proprietary RoboGPT platform achieves widespread adoption among small and medium-sized businesses, driving rapid expansion into new verticals like healthcare and logistics. Revenue scales to over $50M by 2028, justifying a $200M+ valuation at a strong Series C or acquisition, demonstrating the power of accessible AI robotics.
The company continues to grow steadily within its niche, securing a moderate number of new clients and expanding its fleet. Revenue reaches $10-15M by 2028, leading to a Series B or C round at a $75M valuation, reflecting solid execution but facing ongoing competitive pressures in the broader robotics market.
Incumbents or well-funded competitors introduce similar natural language programming features or more cost-effective solutions, eroding Orangewood Labs' competitive edge. Growth stalls below $5M revenue, leading to a down round or acquisition at a significantly reduced valuation of $10M, severely impacting common stock value due to liquidation preferences.
Preference Stack Risk
moderateInvestors hold $5M in liquidation preferences, representing 10% of the estimated current $50M valuation.
Dilution Risk
highAs a Series A stage company, multiple future funding rounds (Series B, C, etc.) are anticipated, which will lead to significant dilution for common stock holders.
Secondary Liquidity
noneThere is no indication of active secondary markets or tender offers for Orangewood Labs' equity at this early stage.
Questions to Ask at the Interview
Strategic questions based on Orangewood Labs's data — designed to show you've done your homework.
- 1
“The recent news mentions 'preparing for a Series A round' in late 2025/early 2026, while the company data indicates a Series A in August 2023. Could you clarify the current funding stage and the strategy for the upcoming capital raise?”
- 2
“Orangewood Labs aims for 20x revenue growth in the next five years and 400+ global clients in two years. What are the key operational and market expansion strategies to achieve these aggressive targets, particularly in scaling manufacturing and client acquisition?”
- 3
“Given the high capital intensity of hardware and the need for future funding, how does the company plan to manage dilution for early employees, and what is the anticipated timeline for a liquidity event (e.g., IPO or acquisition)?”
Community
Valuation Sentiment
Our model estimates -69% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.